Skip to main content

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 117))

Abstract

Studies to characterize Hodgkin and Reed-Sternberg cells in histological sections have yielded many conflicting data over the years. Even with progress in immunohistological technology, the histogenetic derivation of these cells remains unclear. Functional and genetic investigations are hampered by the scarcity of tumor cells in Hodgkin’s disease biopsy samples and the admixture of a variety of nonmalignant cells.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bieber MM, King DP, Strober S, Kaplan HS (1979) Characterization of an E-rosette inhibitor in the serum of patients with Hodgkin’s disease as a glycolipid. Clin Res 27: 81A

    Google Scholar 

  2. Breitmeyer JB (1987) Lymphocyte activation; how T cells communicate. Nature 329: 760–761

    Article  PubMed  CAS  Google Scholar 

  3. Burrichter H, Heit W, Schaadt M, Kirchner HH, Diehl V (1983) Production of colony stimulating factors by Hodgkin cell lines. Int J Cancer 31: 269–274

    Article  PubMed  CAS  Google Scholar 

  4. Cheng G, Minden M, Toyonaga B, Mak T, McCullogh A (1986) T-cell receptor and immunoglobulin gene rearrangements in acute myelobastic leukemia. J Exp Med 163: 414–424

    Article  PubMed  CAS  Google Scholar 

  5. Diehl V, Kirchner HH, Burrichter H, Stein H, Fonatsch C, Gerdes J, Schaadt M, Heit W, Uchanska-Ziegler B, Ziegler A, Heintz H, Sueno K (1982) Characteristics of Hodgkin’s disease-derived cell lines. Cancer Treat Rep 66: 615–632

    PubMed  CAS  Google Scholar 

  6. Drexler HG, Gaedicke G, Lok MS, Diehl V, Minowada J (1986) Hodgkin’s disease derived cell lines HDLM-2 and L 428. Comparison of morphology, immunological and isoenzyme profiles. Leuk Res 10: 487–500

    Article  PubMed  CAS  Google Scholar 

  7. Falk M, Tesch H, Stein H, Diehl V, Jones D, Fonatsch C, Bornkamm G (1987) Phenotype versus immunoglobulin and T-cell receptor genotype of Hodgkin derived cell lines: activation of immature lymphoid cells in Hodgkin’s disease. Int J Cancer 40: 262–269

    Article  PubMed  CAS  Google Scholar 

  8. Fischer RI, Bostick-Bruton F, Sander DN, Scala G, Diehl V (1983) Neoplastic cells obtained from Hodgkin’s disease are potent stimulators of human primary mixed lymphocyte cultures. J Immunol 130: 2666–2670

    Google Scholar 

  9. Fonatsch C, Diehl V, Schaadt M, Burrichter H, Kirchner HH (1986) Cytogenetic investigations in Hodgkin’s disease: I. Involvement of specific chromosomes in marker formation. Cancer Genet Cytogenet 20: 39–52

    Article  PubMed  CAS  Google Scholar 

  10. Giovanella BC, Nilsson K, Zeich L, Yim O, Klein G, Stehlin JS (1979) Growth of diploid, Epstein-Barr-virus-carrying human lymphoblastoid cell lines heterotransplanted into nude mice under immunologically privileged conditions. Int J Cancer 24: 103–113

    Article  PubMed  CAS  Google Scholar 

  11. Jones DB, Scott CS, Wright DH, Stein H, Beverly PCL, Payne SV, Crawford DH (1985) Phenotype analysis of an established cell line derived from a patient with Hodgkin’s disease (HD). Hematol Oncol 3: 133–145

    Article  PubMed  CAS  Google Scholar 

  12. Kamesaki H, Fukuhara S, Tatsumi E, Uchino H, Yamabe H, Miwa H, Shiragawa S, Hatanaka M, Honjo T (1986) Cytochemical, immunologic, chromosomal and molecular genetic analysis of a novel cell line derived from Hodgkin’s disease. Blood 68: 285–292

    PubMed  CAS  Google Scholar 

  13. Kortmann C, Burrichter H, Jahn G, Diehl V, Peter HH (1984) Interleukin-1 activity constitutively generated by Hodgkin derived cell lines. I. Measurement in a human lymphocyte costimulator assay. Immunobiology 166: 318–333

    Article  PubMed  CAS  Google Scholar 

  14. Lozzio BB, Lozzio CB, Machado E (1976) Human myelogenous (Ph1 +) leukemia cell-line; transplantation into athymic mice. JNCI 56: 627–628

    PubMed  CAS  Google Scholar 

  15. Meuer S, Hussey R, Fabbi M, Fox D, Acuto O, Fitzgerald K, Hodgdon J, Protentis J, Schlossman S, Reinherz E (1984) An alternative pathway of T-cell activation: a functional role for the 50 kd T 11 sheep erythrocyte receptor protein. Cell 36: 897–906

    Article  PubMed  CAS  Google Scholar 

  16. Newcom S, Kadin ME, Ansari AA (1988) Production of transforming growth factor beta activity by Ki-1 positive lymphoma cells and analysis of its role in the regulation of Ki-1 positive lymphoma growth. Am J Pathol 131 (3): 569–577

    PubMed  CAS  Google Scholar 

  17. Olsson L, Behnke O, Pleibel N, D’Amore F, Werdelin O, Fry KE, Kaplan HS (1984) Establishment and characterization of a clonal gaint cell line from a patient with Hodgkin’s disease. JNCI 73: 809–830

    PubMed  CAS  Google Scholar 

  18. Pfreundschuh M, Mommerz E, Meissner M, Feller A, Hassa R, Krueger HR, Diehl V (1988) Hodgkin and Reed-Sternberg cells associated monoclonal antibodies HRS-1 and HRS-2 react with activated cells of lymphoid and monocytoid origin. Anticancer Res 8: 217–224

    PubMed  CAS  Google Scholar 

  19. Poppema S, De Jong B, Atmosoerodjo J, Idenburg V, Visser L, De Ley L (1985) Morphologic, immunologic, enzyme histochemical and chromosomal analysis of a cell line derived from Hodgkin’s disease. Evidence for a B-cell origin of Sternberg-Reed cells. Cancer 55: 683–690

    Article  PubMed  CAS  Google Scholar 

  20. Schaadt M, Kirchner H, Fonatsch C, Diehl V (1979) Intracranial heterotransplantation of human hematopoetic cells in “nude”-mice. Int J Cancer 23: 751–561

    Article  PubMed  CAS  Google Scholar 

  21. Schaadt M, Diehl V, Stein H, Fonatsch C, Kirchner H (1980) Two neoplastic cell lines with unique features derived from Hodgkin’s disease. Int J Cancer 26: 723–731

    Article  PubMed  CAS  Google Scholar 

  22. Schell-Frederick E, Radtke H, Sommer H, Helbing I, Burrichter H, Schaadt M, Diehl V (1988) Inhibition of human neutrophil migration by supernatants from Hodgkin’s disease derived cell lines. Eur Clin Invest 18: 290–296

    Article  CAS  Google Scholar 

  23. Schwab U, Stein H, Gerdes J, Lemke H, Kirchner HH, Schaadt M, Diehl V (1982) Production of a monoclonal antibody specific for Hodgkin-and Sternberg-Reed-cells of Hodgkin’s lymphoma and a subset of normal lymphoid cells. Nature 299: 65–67

    Article  PubMed  CAS  Google Scholar 

  24. Stein H, Gerdes J, Schwab U, Lemke H, Mason DY, Ziegler A, Schienle W, Diehl V (1982) Identification of Hodgkin and Sternberg-Reed cells as a unique cell type derived from a newly detected small-cell population. Int J Cancer 30: 445–459

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag Berlin · Heidelberg

About this paper

Cite this paper

Schaadt, M. et al. (1989). Biology of Hodgkin Cell Lines. In: Diehl, V., Pfreundschuh, M., Loeffler, M. (eds) New Aspects in the Diagnosis and Treatment of Hodgkin’s Disease. Recent Results in Cancer Research, vol 117. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83781-4_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-83781-4_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-83783-8

  • Online ISBN: 978-3-642-83781-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics